IBDEI0PJ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11393,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,11393,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,11393,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,11394,0)
 ;;=H40.1211^^77^732^16
 ;;^UTILITY(U,$J,358.3,11394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11394,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Right Eye
 ;;^UTILITY(U,$J,358.3,11394,1,4,0)
 ;;=4^H40.1211
 ;;^UTILITY(U,$J,358.3,11394,2)
 ;;=^5005759
 ;;^UTILITY(U,$J,358.3,11395,0)
 ;;=H40.1221^^77^732^17
 ;;^UTILITY(U,$J,358.3,11395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11395,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Left Eye
 ;;^UTILITY(U,$J,358.3,11395,1,4,0)
 ;;=4^H40.1221
 ;;^UTILITY(U,$J,358.3,11395,2)
 ;;=^5005764
 ;;^UTILITY(U,$J,358.3,11396,0)
 ;;=H40.1231^^77^732^18
 ;;^UTILITY(U,$J,358.3,11396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11396,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Bilateral
 ;;^UTILITY(U,$J,358.3,11396,1,4,0)
 ;;=4^H40.1231
 ;;^UTILITY(U,$J,358.3,11396,2)
 ;;=^5005768
 ;;^UTILITY(U,$J,358.3,11397,0)
 ;;=H40.1233^^77^732^20
 ;;^UTILITY(U,$J,358.3,11397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11397,1,3,0)
 ;;=3^Low-Tension Glaucoma,Severe,Bilateral
 ;;^UTILITY(U,$J,358.3,11397,1,4,0)
 ;;=4^H40.1233
 ;;^UTILITY(U,$J,358.3,11397,2)
 ;;=^5005770
 ;;^UTILITY(U,$J,358.3,11398,0)
 ;;=H40.011^^77^732^21
 ;;^UTILITY(U,$J,358.3,11398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11398,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Right Eye
 ;;^UTILITY(U,$J,358.3,11398,1,4,0)
 ;;=4^H40.011
 ;;^UTILITY(U,$J,358.3,11398,2)
 ;;=^5005724
 ;;^UTILITY(U,$J,358.3,11399,0)
 ;;=H40.012^^77^732^22
 ;;^UTILITY(U,$J,358.3,11399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11399,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,11399,1,4,0)
 ;;=4^H40.012
 ;;^UTILITY(U,$J,358.3,11399,2)
 ;;=^5005725
 ;;^UTILITY(U,$J,358.3,11400,0)
 ;;=H59.41^^77^732^25
 ;;^UTILITY(U,$J,358.3,11400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11400,1,3,0)
 ;;=3^Blebitis,Stage 1
 ;;^UTILITY(U,$J,358.3,11400,1,4,0)
 ;;=4^H59.41
 ;;^UTILITY(U,$J,358.3,11400,2)
 ;;=^5006426
 ;;^UTILITY(U,$J,358.3,11401,0)
 ;;=H40.1111^^77^732^6
 ;;^UTILITY(U,$J,358.3,11401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11401,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,11401,1,4,0)
 ;;=4^H40.1111
 ;;^UTILITY(U,$J,358.3,11401,2)
 ;;=^5138537
 ;;^UTILITY(U,$J,358.3,11402,0)
 ;;=H40.1121^^77^732^7
 ;;^UTILITY(U,$J,358.3,11402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11402,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,11402,1,4,0)
 ;;=4^H40.1121
 ;;^UTILITY(U,$J,358.3,11402,2)
 ;;=^5138542
 ;;^UTILITY(U,$J,358.3,11403,0)
 ;;=H40.013^^77^732^4
 ;;^UTILITY(U,$J,358.3,11403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11403,1,3,0)
 ;;=3^Glaucoma Suspect,Low Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,11403,1,4,0)
 ;;=4^H40.013
 ;;^UTILITY(U,$J,358.3,11403,2)
 ;;=^5005726
 ;;^UTILITY(U,$J,358.3,11404,0)
 ;;=H40.023^^77^732^5
 ;;^UTILITY(U,$J,358.3,11404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11404,1,3,0)
 ;;=3^Glaucoma Suspect,High Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,11404,1,4,0)
 ;;=4^H40.023
 ;;^UTILITY(U,$J,358.3,11404,2)
 ;;=^5005730
 ;;^UTILITY(U,$J,358.3,11405,0)
 ;;=H40.1132^^77^732^11
 ;;^UTILITY(U,$J,358.3,11405,1,0)
 ;;=^358.31IA^4^2
